Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.
Chronic kidney disease (CKD) is much more common than people recognize, and habitually goes undetected and undiagnosed until the disease is well advanced or when their kidney functions is down to 25% of normal function. Genetic and non-genetic factors contribute to cause CKD. Non-genetic factors include hypertension, High level of DNA damage due to the production of reactive oxygen species and nucleic acid oxidation has been reported in CKD patients. Main genetic factor which causes CKD is diabetic nephropathy. A three- to nine-fold greater risk of End Stage Renal Disease (ESRD) is observed in individuals with a family history of ESRD. This greater risk have led researchers to search for genes linked to diabetic and other forms of nephropathy for the management of CKD. Multicenter consortia are currently recruiting large numbers of multiplex diabetic families with index cases having nephropathy for linkage and association analyses using various cytogenetic techniques. In addition, large-scale screening studies are underway, with the goals of better defining the overall prevalence of chronic kidney disease, as well as educating the population about risk factors for nephropathy, including family history. Cytogenetic biomarkers play an imperative role for the linkage study using G banding and detection of genomic instability in CKD patients. Classical and molecular cytogenetic tools with cytogenetic biomarkers provide remarkable findings in CKD patients. The aim of the present review is to draw outline of classical and molecular cytogenetic findings in CKD patients and their possible role in management to reduce genomic instability in CKD patients.
Department of Research, Bhopal Memorial Hospital and Research Centre (ICMR), Bhopal (MP), India-462038.
Zeba
Z
Khan
Department of Surgical Oncology, Bhopal Memorial Hospital and Research Centre (ICMR), Bhopal (MP), India-462038.
Manoj
M
Pandey
Department of Research, Bhopal Memorial Hospital and Research Centre (ICMR), Bhopal (MP), India-462038.
Ravindra M
RM
Samartha
Biomarkers; CKD; Cytogenetics; DNA damage; FISH; Micronucleus frequency; Neoplasm